Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
ABL1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 345.0 | Evidence | |||||
ABL1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
ABL1 | CRKL | CRKL: Crk-like protein | 275.0 | Evidence | |||||
ABL1 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 258.0 | Evidence | |||||
ABL1 | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 221.0 | Evidence | |||||
ABL1 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 206.0 | Evidence | |||||
ABL1 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 206.0 | Evidence | |||||
ABL1 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 206.0 | Evidence | |||||
ABL1 | INSR | INSR: Insulin receptor precursor | 147.0 | Evidence | |||||
ABL1 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 143.0 | Evidence | |||||
ABL1 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 137.0 | Evidence | |||||
ABL1 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 137.0 | Evidence | |||||
ABL1 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 135.0 | Evidence | |||||
ABL1 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 135.0 | Evidence | |||||
ABL1 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 135.0 | Evidence | |||||
ABL1 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 125.0 | Evidence | |||||
ABL1 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 119.0 | Evidence | |||||
ABL1 | STAT3 | 119.0 | Evidence | ||||||
ABL1 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 119.0 | Evidence | |||||
ABL1 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 119.0 | Evidence | |||||
ABL1 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence | |||||
ABL1 | SYK | SYK: Tyrosine-protein kinase SYK | 116.0 | Evidence | |||||
ABL1 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 109.0 | Evidence | |||||
ABL1 | CSK | CSK: Tyrosine-protein kinase CSK | 109.0 | Evidence | |||||
ABL1 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 109.0 | Evidence | |||||
ABL1 | VAV1 | VAV1, VAV: Proto-oncogene vav | 109.0 | Evidence | |||||
ABL1 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 109.0 | Evidence | |||||
ABL1 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 109.0 | Evidence | |||||
ABL1 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 107.0 | Evidence | |||||
ABL1 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 102.0 | Evidence | |||||
ABL1 | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 101.0 | Evidence | |||||
ABL1 | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 101.0 | Evidence | |||||
ABL1 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 89.30 | Evidence | |||||
ABL1 | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 89.20 | Evidence | |||||
ABL1 | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 89.20 | Evidence | |||||
ABL1 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 89.20 | Evidence | |||||
ABL1 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 88.80 | Evidence | |||||
ABL1 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 88.80 | Evidence | |||||
ABL1 | APS | SH2B2, APS: SH2B adapter protein 2 | 88.80 | Evidence | |||||
ABL1 | LYN | LYN: Tyrosine-protein kinase Lyn | 88.80 | Evidence | |||||
ABL1 | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 88.80 | Evidence | |||||
ABL1 | HCK | N/A | 78.20 | Evidence | |||||
ABL1 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 70.50 | Evidence | |||||
ABL1 | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 66.50 | Evidence | |||||
ABL1 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 66.50 | Evidence | |||||
ABL1 | MET | MET: Hepatocyte growth factor receptor precursor | 58.60 | Evidence | |||||
ABL1 | GRB10 | N/A | 56.20 | Evidence | |||||
ABL1 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 35.30 | Evidence |